Rogosin Institute Home Dialysis Training Center Opens In Carroll Gardens
CARROLL GARDENS – Earlier this month, the Rogosin Institute cut the ribbon at its first free-standing home dialysis treatment and education center in NYC, where patients can learn how to treat kidney disease at home.
A leader in kidney disease care and research, The Rogosin Institute is also one of the largest independent, not-for-profit dialysis providers in the country, with nine dialysis centers located in NYC. Affiliated with New York-Presbyterian Hospital and Weill Cornell Medicine, Rogosin provides health services including prevention and detection of kidney disease and treats more serious problems that require dialysis and transplantation. Rogosin also works to prevent and care for conditions that contribute to kidney disease, such as diabetes and hypertension.
The new location at 527 Court Street (between W 9th & Garnet Streets) is the first free-standing specialized home dialysis training and treatment center in NYC that provides training for all forms of dialysis for both patients and health care providers. It is particularly important to have this treatment and educational center in Brooklyn because the borough has one of the lowest rates of home dialysis in the country, according to an announcement for the new facility—approximately 2% versus the 10% national average.
Patients who dialyze at home “have fewer medical complications” and “a better quality of life” than those who undergo treatment at a medical facility, the announcement adds.
“Rogosin is leading the way to educate and help many more people with kidney disease in
Brooklyn to take more responsibility for their own treatments and overall care,” President of Rogosin, Barry Smith, M.D., said in a statement. “Dialyzing at home gives them more flexibility to work, care for their families, and manage their health and time on their own terms, achieving better care at lower cost.”
“Combining patient and staff education in a free-standing facility is a novel concept and consistent with our goal to be a leader in innovation in kidney care,” Smith added.
